31 May 2017: Sysmex Acquires UK Company to Expand into New Business Domains toward Personalised Medicine

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has reached an agreement with Oxford Gene Technology IP Limited (HQ: Oxfordshire county, United Kingdom; CEO: Michael Evans; “OGT”) to acquire all shares in OGT (the “Acquisition”). Through this move, Sysmex aims to obtain OGT’s business and expertise in the cytogenetics1 domain and its reagent development capabilities used in next-generation sequencers (NGSs)2, thereby reinforcing its base in the life science business.

25 May 2017: Sysmex Receives Award in the 2017 National Commendation for Invention

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has received the Invention Award in the National Commendation for Invention1, sponsored by the Japan Institute of Invention and Innovation, for its hematology analyzers that enables the rapid evaluation of the effects of administering iron preparations. The award ceremony is scheduled to be held in Tokyo on Monday, June 12.

21 May 2017: Sysmex Announce Senior Management Changes

Sysmex New Zealand has appointed a new senior management team. James Webster has stepped aside as Sysmex New Zealand CEO to focus his full attention on his role as Sysmex Australia CEO. Assuming the position of Sysmex New Zealand CEO is Arjit Bhana, formerly the company’s General Manager. James Webster said “I may have moved […]